Home » Topics » BioWorld Science

BioWorld Science
RSS

CRISPR Therapeutics AG presents new CAR Tcells for immuno-oncology

Aug. 20, 2021

AAV9 gene therapy enters clinical development for Canavan disease

Aug. 20, 2021

Coeptis Therapeutics and VyGen-Bio to codevelop products targeting CD38 cancers

Aug. 20, 2021

IBI-362 demonstrates body weight-lowering effect in phase I trial

Aug. 20, 2021

Phase II data show improvements in GM2 gangliosidosis with IB-1001

Aug. 20, 2021

Fate Therapeutics details responses seen in trials of FT-516 and FT-596

Aug. 20, 2021

Vyant Bio to collaborate with Cyclica on discovery of treatments for CDKL5 deficiency disorder

Aug. 20, 2021

LP-184 induces tumor growth inhibition in glioblastoma models

Aug. 20, 2021

Children's Medical Center patents ALK CAR for melanoma and neuroblastoma

Aug. 20, 2021

Esteve Pharmaceuticals presents new analgesic drugs

Aug. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...